Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib-Reference-Cited by-同舟云学术

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib

Published:2020-10-16 Issue:42 Volume:99 Page:e22782
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Tomonari Tetsu,Sato Yasushi,Tanaka Hironori,Tanaka Takahiro,Taniguchi Tatsuya,Sogabe Masahiro,Okamoto Koichi,Miyamoto Hiroshi,Muguruma Naoki,Saito Yu,Imura Satoru,Bando Yoshimi,Shimada Mitsuo,Takayama Tetsuji

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference22 articles.

1. Cancer statistics, 2018;Siegel;CA,2018

2. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet (London, England),2018

3. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?;Adam;J Clin Oncol,2009

4. Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study;Sato;Gastric Cancer,2017

5. Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma;Takeyama;Surg Today,2018

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Resection and Transplantation in the Era of Checkpoint Inhibitors;JHEP Reports;2024-08

2. Exploring the Therapeutic Potential of Lenvatinib: A Complete Pathological Response in an Operable Case of Hepatocellular Carcinoma;Cureus;2024-07-09

3. Prognostic factors in patients with hepatocellular cancer with progression after liver transplantation;Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2024-06-15

4. Pathologically successful conversion hepatectomy for advanced giant hepatocellular carcinoma after multidisciplinary therapy: A case report and review of literature;World Journal of Gastrointestinal Oncology;2024-04-15

5. Downstaging Techniques for Hepatocellular Carcinoma in Candidates Awaiting Liver Transplantation;Surgical Clinics of North America;2024-02